Literature DB >> 19937618

The interaction of zinc(II) and hydroxamic acids and a metal-triggered Lossen rearrangement.

Lucie Duchácková1, Jana Roithová.   

Abstract

The structure and reactivity of a complex of zinc(II), water, acetic acid, and acetohydroxamic acid, in which one of the acids is deprotonated, is investigated by means of mass spectrometry, labeling studies, and density functional calculations to unravel the exceptional binding properties of hydroxamic acids towards zinc-containing enzymes at the molecular level. It is shown that acetohydroxamic acid is deprotonated in the complex, whereas acetic acid is present in its neutral form. The binding energies of the ligands towards zinc increase in the following order: water<acetic acid<acetohydroxamic acid. The structure of the complex and its fragmentation provide experimental evidence for the proposed mode of operation of drugs based on hydroxamic acids. Furthermore, coordinatively unsaturated complexes of zinc and acetohydroxamic acid undergo a zinc-assisted Lossen rearrangement followed by elimination of water if acetohydroxamic acid is present as a neutral ligand, or by loss of methylisocyanate if acetohydroxamic acid is deprotonated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937618     DOI: 10.1002/chem.200901645

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  6 in total

1.  Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site.

Authors:  David P Martin; Zachary S Hann; Seth M Cohen
Journal:  Inorg Chem       Date:  2013-05-24       Impact factor: 5.165

2.  Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?

Authors:  Sida Shen; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2015-11-25       Impact factor: 3.466

3.  Monoaurated vs. diaurated intermediates: causality or independence?

Authors:  Mariarosa Anania; Lucie Jašíková; Jan Zelenka; Elena Shcherbachenko; Juraj Jašík; Jana Roithová
Journal:  Chem Sci       Date:  2019-12-13       Impact factor: 9.825

4.  Chemoselectivity in the Oxidation of Cycloalkenes with a Non-Heme Iron(IV)-Oxo-Chloride Complex: Epoxidation vs. Hydroxylation Selectivity.

Authors:  Thibault Terencio; Erik Andris; Ilaria Gamba; Martin Srnec; Miquel Costas; Jana Roithová
Journal:  J Am Soc Mass Spectrom       Date:  2019-08-09       Impact factor: 3.109

5.  The Intermediates in Lewis Acid Catalysis with Lanthanide Triflates.

Authors:  Guilherme L Tripodi; Thiago C Correra; Célio F F Angolini; Bruno R V Ferreira; Philippe Maître; Marcos N Eberlin; Jana Roithová
Journal:  European J Org Chem       Date:  2019-05-24

Review 6.  Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives.

Authors:  Robert Jenke; Nina Reßing; Finn K Hansen; Achim Aigner; Thomas Büch
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.